Education
About Us
Working with TipRanks
Follow Us
China Healthwise Holdings Ltd. (HK:0348)
:0348
0348 Stock Chart & Stats
HK$0.14
>-HK$0.01(-2.78%)
At close: 4:00 PM EST
HK$0.14
>-HK$0.01(-2.78%)
Day’s Range― - ―
52-Week RangeHK$0.07 - HK$0.22
Previous CloseN/A
Volume850.00K
Average Volume (3M)735.98K
Market Cap
HK$107.10M
Enterprise ValueHK$210.66M
Total Cash (Recent Filing)HK$47.17M
Total Debt (Recent Filing)HK$107.93M
Price to Earnings (P/E)―
Beta1.07
Next Earnings
Mar 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding770,480,830
10 Day Avg. Volume624,920
30 Day Avg. Volume735,980
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)-6.50
Price to Sales (P/S)1.05
P/FCF Ratio38.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Market PositionChina Healthwise's focus on holistic health solutions positions it well in the growing market for alternative and complementary healthcare, potentially increasing its customer base and revenue streams.
Revenue StreamsDiverse revenue streams from health supplements, wellness products, and TCM services provide a buffer against market fluctuations and support long-term growth potential.
Industry TrendsThe increasing consumer preference for preventive healthcare and natural remedies aligns with China Healthwise's offerings, supporting sustained demand and potential market expansion.
Bears Say
Revenue DeclineConsistent revenue decline over recent years suggests challenges in maintaining market share and competitiveness, potentially impacting long-term financial health.
Negative EquityNegative equity indicates potential solvency issues, raising concerns about the company's ability to meet long-term obligations and sustain operations.
Cash Flow IssuesZero operating cash flow in 2024 highlights cash management issues, limiting the company's ability to invest in growth and manage financial obligations.
China Healthwise Holdings News
0348 FAQ
What was China Healthwise Holdings Ltd.’s price range in the past 12 months?
China Healthwise Holdings Ltd. lowest stock price was HK$0.07 and its highest was HK$0.22 in the past 12 months.
What is China Healthwise Holdings Ltd.’s market cap?
China Healthwise Holdings Ltd.’s market cap is HK$107.10M.
When is China Healthwise Holdings Ltd.’s upcoming earnings report date?
China Healthwise Holdings Ltd.’s upcoming earnings report date is Mar 31, 2026 which is in 36 days.
How were China Healthwise Holdings Ltd.’s earnings last quarter?
China Healthwise Holdings Ltd. released its earnings results on Aug 27, 2025. The company reported HK$0.002 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.002.
Is China Healthwise Holdings Ltd. overvalued?
According to Wall Street analysts China Healthwise Holdings Ltd.’s price is currently Overvalued.
Does China Healthwise Holdings Ltd. pay dividends?
China Healthwise Holdings Ltd. does not currently pay dividends.
What is China Healthwise Holdings Ltd.’s EPS estimate?
China Healthwise Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Healthwise Holdings Ltd. have?
China Healthwise Holdings Ltd. has 770,480,830 shares outstanding.
What happened to China Healthwise Holdings Ltd.’s price movement after its last earnings report?
China Healthwise Holdings Ltd. reported an EPS of HK$0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.947%.
Which hedge fund is a major shareholder of China Healthwise Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:0348
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Healthwise Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
101.19%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1.34%
Trailing 12-Months
Company Description
China Healthwise Holdings Ltd.
China Healthwise Holdings Limited, an investment holding company, sells Chinese health products in Hong Kong. It operates through Chinese Health Products, Money Lending Business, and Investment in Financial Instruments segments. The company sells Chinese and other pharmaceutical products, health products, ginseng, and dried seafood products to wholesalers and retailers. It also sells Chinese health products online. The company was formerly known as Haier Healthwise Holdings Limited and changed its name to China Healthwise Holdings Limited in January 2017. China Healthwise Holdings Limited is headquartered in Central, Hong Kong.
Technical Analysis
Innovative Pharmaceutical Biotech
―
Green International Holdings Limited
―
Kingworld Medicines Group Ltd.
―
Universal Health International Group Holding Ltd.
―
Tycoon Group Holdings Limited
―